AZN
AstraZeneca PLC
NYSE · Healthcare · Drug Manufacturers - General · GB
$166.08
−0.04%Forward multiples
Based on analyst estimates
- P/E forward
- 15.62x
- P/E 2026E
- 16.21x
- P/E 2027E
- 14.49x
- P/E 2028E
- 13.01x
- P/S forward
- 3.95x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.71x
- PEG TTM
- 0.43x
- Price / book
- 5.13x
- Price / sales
- 4.20x
- Price / cash flow
- 18.65x
Enterprise value
- Enterprise value
- $284.9B
- EV / sales
- 4.64x
- EV / EBITDA
- 13.78x
- EV / EBIT
- 20.39x
- Market cap
- $257.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026